Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of LY01008 vs Avastin in Healthy Chinese Males
NCT05110118Phase 1Completed
- Sponsor
- Boan Biotech
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bevacizumab MB02 in metastatic colorectal cancer (mCRC) and non-small cell lung cancer (NSCLC) (2 arms), sponsored by Boan Biotech. Primary endpoints: Area under the plasma concentration-time curve from time zero to the last measurable concentration at Day 99, Area under the plasma concentration-time curve from time zero to infinity at Day 99 and 4 more. Started Aug 2020; status: completed.
02
Drugs
bevacizumab MB02
03
Conditions
metastatic colorectal cancer (mCRC)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05110118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110118.